Skip to main content
. 2018 Dec 17;9:1094. doi: 10.3389/fneur.2018.01094

Table 1.

Demographic data and p-syn deposition of patients with GBA1 mutation.

Patient no. Duration of disease (y) H&Ystage UPDRS part III Annual UPDRS III progression Bradykinesia score Subtype GBA1 mut. p-syn pos biopsy site p-syn pos structures No. of positive struct.
1 14 3 70 5 1.7 Equivalent N370S LL ves, db, ep 3
2 6 2 48 8 1.5 Equivalent N370S 0
3 17 2 34 2 0.6 Equivalent N370S LL, Th10 subepi, intraepi,ves, db 4
4 6 2.5 35 5.8 1.7 Equivalent N370S 0
5 5 2 32 6.4 1.1 Equivalent N370S UL, Th10 db 2
6 1 2 10 10 0.5 Tremor dominant L444P 0
7 8 3 49 6.1 2.5 Equivalent E326K UL, LL, C7 db, ves, ep 4
8 14 2 32 2.3 1.6 Equivalent E326K UL subepi 1
9 14 3 53 3.8 2.6 Equivalent E326K UL, LL, C7 db, sg 4
10 2 2 36 18 1.8 Acinetic-rigid N370S 0

No., number; y, years; H&Y, Hoehn&Yahr; GBA1, glucocerebrosidase gene; p-syn, phospho-alpha-synuclein; pos, positive; struct., structures; LL, lower leg; UL, upper leg; ves, vessel; db, dermal nerve bundle; ep, erector pilorum muscle; subepi, subepidermal; intraepi, intraepidermal; sg, sweat gland; UPDRS, Unified Parkinson Disease Rating Scale.